|
[1]
|
葛赛, 王晰程. 家族性腺瘤性息肉病的诊疗进展[J]. 肿瘤综合治疗电子杂志, 2022, 8(1): 107-112.
|
|
[2]
|
汪昭明, 袁捷, 赵子夜, 于恩达. 家族性腺瘤性息肉病的结直肠外表现研究进展[J]. 山东医药, 2022, 62(11): 87-91.
|
|
[3]
|
葛赛, 王晰程. 家族性腺瘤性息肉病相关硬纤维瘤的分子机制及诊疗进展[J]. 结直肠肛门外科, 2023, 29(2): 103-109.
|
|
[4]
|
李舒, 方志伟. 硬纤维瘤治疗策略的变化及新进展[J]. 中国肿瘤临床, 2023, 50(3): 130-134.
|
|
[5]
|
Desmoid Tumor Working Group (2020) The Management of Desmoid Tumours: A Joint Global Consensus-Based Guideline Approach. European Journal of Cancer, 127, 96-107.
|
|
[6]
|
van Houdt, W.J., Husson, O., Patel, A., Jones, R.L., Smith, M.J.F., Miah, A.B., et al. (2019) Outcome of Primary Desmoid Tumors at All Anatomic Locations Initially Managed with Active Surveillance. Annals of Surgical Oncology, 26, 4699-4706. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Yang, W. and Ding, P. (2023) Update on Familial Adenomatous Polyposis-Associated Desmoid Tumors. Clinics in Colon and Rectal Surgery, 36, 400-405. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Nieuwenhuis, M.H., Casparie, M., Mathus‐Vliegen, L.M.H., Dekkers, O.M., Hogendoorn, P.C.W. and Vasen, H.F.A. (2010) A Nation‐Wide Study Comparing Sporadic and Familial Adenomatous Polyposis‐Related Desmoid‐Type Fibromatoses. International Journal of Cancer, 129, 256-261. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
黄远健, 胥子玮. 腹内型侵袭性纤维瘤的临床特征[J]. 中国肿瘤外科杂志, 2025, 17(1): 75-79, 86.
|
|
[10]
|
韩猛虎. 韧带样纤维瘤误诊临床分析[J]. 临床误诊误治, 2020, 33(6): 45-49.
|
|
[11]
|
Gounder, M., Ratan, R., Alcindor, T., Schöffski, P., van der Graaf, W.T., Wilky, B.A., et al. (2023) Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors. New England Journal of Medicine, 388, 898-912. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Gounder, M.M., Mahoney, M.R., Van Tine, B.A., Ravi, V., Attia, S., Deshpande, H.A., et al. (2018) Sorafenib for Advanced and Refractory Desmoid Tumors. New England Journal of Medicine, 379, 2417-2428. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
李舒, 方志伟, 刘佳勇, 等. 多柔比星脂质体联合达卡巴嗪治疗不可手术切除硬纤维瘤的疗效初探[J]. 中国肿瘤临床, 2021, 48(14): 716-720.
|